🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/03/2007 | 41,55 | 41,77 | 40,72 | 40,91 | -1,89% | 2,52% | 487.178 |
| 06/03/2007 | 41,43 | 41,92 | 41,36 | 41,70 | +1,27% | 1,35% | 109.645 |
| 05/03/2007 | 42,30 | 42,30 | 41,14 | 41,17 | -2,74% | 2,74% | 417.635 |
| 02/03/2007 | 42,37 | 42,67 | 42,22 | 42,33 | -0,70% | 1,06% | 256.373 |
| 01/03/2007 | 41,55 | 42,78 | 41,10 | 42,63 | +1,33% | 4,05% | 183.544 |
| 28/02/2007 | 41,17 | 42,60 | 41,17 | 42,07 | +2,18% | 3,45% | 680.313 |
| 27/02/2007 | 43,12 | 43,76 | 40,57 | 41,17 | -6,46% | 7,38% | 516.754 |
| 26/02/2007 | 43,79 | 44,54 | 43,79 | 44,02 | +0,26% | 1,71% | 83.142 |
| 23/02/2007 | 44,47 | 44,73 | 43,79 | 43,91 | -1,01% | 2,10% | 124.927 |
| 22/02/2007 | 44,65 | 45,25 | 44,28 | 44,35 | -0,67% | 2,18% | 166.739 |
| 21/02/2007 | 43,79 | 44,92 | 43,79 | 44,65 | +1,10% | 2,56% | 376.358 |
| 20/02/2007 | 43,46 | 44,47 | 43,12 | 44,17 | +1,81% | 3,10% | 124.045 |
| 16/02/2007 | 43,53 | 44,02 | 43,12 | 43,38 | -0,77% | 2,06% | 84.425 |
| 15/02/2007 | 43,27 | 44,47 | 43,23 | 43,72 | +0,78% | 2,85% | 230.378 |
| 14/02/2007 | 43,83 | 44,47 | 43,19 | 43,38 | -1,19% | 2,90% | 309.619 |
| 13/02/2007 | 44,13 | 44,54 | 43,79 | 43,91 | -0,76% | 1,70% | 227.840 |
| 12/02/2007 | 44,35 | 44,50 | 43,01 | 44,24 | -0,08% | 3,38% | 303.608 |
| 09/02/2007 | 45,07 | 45,10 | 44,02 | 44,28 | -1,33% | 2,41% | 158.777 |
| 08/02/2007 | 44,92 | 45,74 | 44,65 | 44,88 | -0,42% | 2,42% | 252.045 |
| 07/02/2007 | 46,68 | 46,90 | 45,07 | 45,07 | -3,68% | 3,93% | 251.377 |
| 06/02/2007 | 47,39 | 47,42 | 46,41 | 46,79 | -1,19% | 2,13% | 2.017.295 |
| 05/02/2007 | 47,61 | 47,61 | 46,30 | 47,35 | -0,16% | 2,75% | 174.567 |
| 02/02/2007 | 47,16 | 47,72 | 45,14 | 47,42 | -0,08% | 5,48% | 748.254 |
| 01/02/2007 | 48,66 | 48,73 | 47,12 | 47,46 | -2,39% | 3,31% | 974.517 |
| 31/01/2007 | 47,99 | 48,77 | 46,94 | 48,62 | +0,70% | 3,82% | 349.427 |
| 30/01/2007 | 46,79 | 48,55 | 46,23 | 48,28 | +3,45% | 4,96% | 378.361 |
| 29/01/2007 | 46,11 | 46,82 | 45,48 | 46,68 | +1,46% | 2,92% | 734.414 |
| 26/01/2007 | 43,79 | 46,04 | 43,61 | 46,00 | +4,77% | 5,56% | 895.650 |
| 25/01/2007 | 43,04 | 44,92 | 43,04 | 43,91 | +1,65% | 4,35% | 203.287 |
| 24/01/2007 | 42,33 | 43,42 | 42,11 | 43,19 | +1,85% | 3,09% | 165.109 |